Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Otolaryngologic Clinics of North AmericaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The Nose and the Lung: United Airway Disease?.Front Pediatr. 2017; 5: 44
- International Consensus Statement on Allergy and Rhinology.Allergic Rhinitis Int Forum Allergy Rhinol. 2018; 8: 108-352
- Current understanding of the pathophysiology of allergic rhinitis.Immunol Allergy Clin N Am. 2011; 31: 433-439
- Chronic rhinosinusitis with nasal polyps.N Engl J Med. 2019; 381: 55-63
- Clinical updates in aspirin-exacerbated respiratory disease.Allergy Asthma Proc. 2019; 40: 4-6
- Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice.BMJ. 2004; 328: 434
- Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature.J Allergy Clin Immunol. 2015; 135 (e671): 676-681
- The upper and lower airways: the epidemiological and pathophysiological connection.Allergy Asthma Proc. 2008; 29: 553-556
- The unified airway--conceptual framework.Otolaryngol Clin N Am. 2008; 41: 257-266
- Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease.Clin Rev Allergy Immunol. 2019; 56: 219-233
- Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.J Allergy Clin Immunol. 2010; 125 (e1048): 1046-1053
- Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes.Paediatr Respir Rev. 2019; S1526–0542: 30081-30088
- T-helper type 2-driven inflammation defines major subphenotypes of asthma.Am J Respir Crit Care Med. 2009; 180: 388-395
- Type 2 inflammation in asthma--present in most, absent in many.Nat Rev Immunol. 2015; 15: 57-65
- Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis.J Allergy Clin Immunol Pract. 2019; 7 (e2813): 2812-2820
- Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.J Allergy Clin Immunol. 2016; 137 (e1444): 1449-1456
- Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis.J Allergy Clin Immunol. 2015; 136: 1431-1440
- Immunomodulators in chronic rhinosinusitis.World J Otorhinolaryngol Head Neck Surg. 2018; 4: 186-192
- IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps.Am J Respir Crit Care Med. 2013; 188: 432-439
- Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.Nat Immunol. 2011; 12: 1055-1062
- Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.J Allergy Clin Immunol. 2013; 132 (e512): 593-600
- Role of IL-17 in asthma pathogenesis and its implications for the clinic.Expert Rev Respir Med. 2019; 13: 1057-1068
- T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma.J Allergy Clin Immunol. 2009; 123: 1185-1187
- Identification of IL-17F/frequent exacerbator endotype in asthma.J Allergy Clin Immunol. 2017; 140: 395-406
- Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma.Allergy. 2015; 70: 236-240
- Increased serum IL-17 is an independent risk factor for severe asthma.Respir Med. 2010; 104: 1131-1137
- Increased IL-17A secreting CD41 T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity.Clin Exp Allergy. 2013; 43: 1018-1026
- Effects of anti-IL-17 on inflammation, remodeling, and oxidative stress in an experimental model of asthma exacerbated by LPS.Front Immunol. 2017; 8: 1835
- Inhibition of BET bromodomains restores corticosteroid responsiveness in a mixed granulocytic mouse model of asthma.Biochem Pharmacol. 2018; 154: 222-233
- Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma.J Allergy Clin Immunol. 2014; 134 (e7): 1175-1186
- Th17 regulating lower airway disease.Curr Opin Allergy Clin Immunol. 2016; 16: 1-6
- Mechanism of T(H)2/T(H)17-predominant and neutrophilic T(H)2/T(H)17-low subtypes of asthma.J Allergy Clin Immunol. 2017; 139 (e4): 1548-1558
- The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies.Ann Rheum Dis. 2019; 78 ([published correction appears in Ann Rheum Dis. 2020 Jan;79(1):e12]): 1167-1178
- Urinary leukotriene E4.Immunol Allergy Clin North Am. 2007; 27: 651-664
- Urinary leukotriene E4 as a biomarker of exposure, susceptibility and risk in asthma.Immunol Allergy Clin North Am. 2012; 32: 433-445
- Diagnostic utility of urinary LTE4 in asthma, allergic rhinitis, chronic rhinosinusitis, nasal polyps, and aspirin sensitivity.J Allergy Clin Immunol Pract. 2016; 4: 665-670
- Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis.Thorax. 2005; 60: 902-908
- Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals.Am J Respir Crit Care Med. 2000; 161: 1881-1886
- Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease.World J Otorhinolaryngol Head Neck Surg. 2018; 4: 162-168
- NSAID-ERD syndrome: the new hope from prevention, early diagnosis, and new therapeutic targets.Curr Allergy Asthma Rep. 2020; 20: 10
- Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.Am Rev Respir Dis. 1992; 146: 96-103
- Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis.Otolaryngol Head Neck Surg. 2022; 166: 224-232
- Effect of zileuton and celecoxib on urinary LTE4 and PGE M levels in smokers.Cancer Prev Res (Phila). 2013; 6: 646-655
- Urinary leukotriene E4 as a biomarker of exposure, susceptibility, and risk in asthma: an update.Immunol Allergy Clin North Am. 2018; 38: 599-610
- Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.Am J Respir Crit Caremed. 2002; 166: 1212-1217
- Integrating the microbiota of the respiratory tract with the unified airway model. 126. Respiratory Medicine WB Saunders Ltd, 2017: 68-74
- The microbiome of the upper respiratory tract in health and disease.BMC Biol [Internet. 2019; 17 (Available at:): 87
- First insights into the diverse human archaeome: specific detection of archaea in the gastrointestinal tract, lung, and nose and on skin.MBio. 2017; 8
- Fungal microbiota in chronic airway inflammatory disease and emerging relationships with the host immune response.Front Microbiol. 2017; 8
- The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes.Int Forum Allergy Rhinol [Internet]. 2014; 4 (Available at:): 259-265
- Comparative viral sampling in the sinonasal passages; different viruses at different sites.Front Cell Infect Microbiol. 2018; 8
- Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children.Nat Immunol. 2019; 20: 637-651
- Next generation sequencing and the microbiome of chronic Rhinosinusitis: a primer for clinicians and review of current research, its limitations, and future Directions.Ann Otol Rhinol Laryngol. 2016; 125 ([cited 2020 Jan 2];Available at:): 613-621
- Analysis of Sinonasal microbiota in exacerbations of chronic Rhinosinusitis subgroups.OTO Open. 2019; 3 (2473974X1987510)
- The potential of high-throughput DNA sequencing of the paranasal sinus microbiome in diagnosing odontogenic sinusitis.Otolaryngol Head Neck Surg [Internet]. 2019; 161 ([cited 2020 Jan 2];Available at:): 1043-1047
- Determining the utility of standard hospital microbiology testing: comparing standard microbiology cultures with DNA sequence analysis in patients with chronic sinusitis.World J Otorhinolaryngol – Head Neck Surg. 2019; 5: 82-87
- Associations between fungal and bacterial microbiota of airways and asthma endotypes.J Allergy Clin Immunol. 2019; 144 (e7): 1214-1227
- Fungi in bronchiectasis: a concise review.Int J Mol Sci. 2018; 19: 142
- The lung mycobiome: an emerging field of the human respiratory microbiome.Front Microbiol. 2015; 6: 89
- The lung mycobiome in the nextgeneration sequencing era.Virulence. 2017; 8: 334-341
- Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease.J Allergy Clin Immunol. 2018; 142: 407-414
- Evaluation of malassezia and common fungal pathogens in subtypes of chronic rhinosinusitis.Int Forum Allergy Rhinol. 2016; 6: 950-955
- Revisiting the controversy: The role of fungi in chronic rhinosinusitis.Int Forum Allergy Rhinol. 2021; 11: 1577-1587
- Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4.Science. 2013; 341: 792-796
- Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and Alternaria in a nasal explant model.Laryngoscope. 2007; 117: 51-57
- Nasal mucosa expression of lactoferrin in patientswith chronic rhinosinusitis.Laryngoscope. 2007; 117: 2030-2035
- Distinguishing molecular features of allergic fungal rhinosinusitis.Otolaryngol Head Neck Surg. 2018; 159: 185-193
- Understanding the role of biofilms and superantigens in chronic rhinosinusitis.Curr Otorhinolaryngol Rep. 2018; 6: 253-262
- The bacterial superantigen and superantigenlike proteins.Immunol Rev. 2008; 225: 226-243
- microbiology SL-T in, 2013 undefined. Probiotic strategies for treatment of respiratory diseases. Elsevier [Internet].([cited 2019 Dec 18]. Available at:)
- Development of Aspergillus protease with ovalbumin-induced allergic chronic rhinosinusitis model in the mouse.Am J Rhinol Allergy. 2014; 28: 465-470
- Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbumin.Eur Arch Otorhinolaryngol. 2017; 274: 3899-3906
- Multiple airborne allergeninduced eosinophilic chronic rhinosinusitis murine model.Eur Arch Otorhinolaryngol. 2019; 276: 2273-2282
- STAT6 Blockade Abrogates Aspergillus-Induced Eosinophilic Chronic Rhinosinusitis and Asthma, A Model of Unified Airway Disease.Front Immunol. 2022; 13: 818017
- Asthma Management for the Otolaryngologist.Otolaryngol Clin N Am. 2017; 50: 1065-1076
- Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.Lancet. 2003; 361: 1071-1076
- Inhaled beclomethasone versus placebo for chronic asthma.Cochrane Database Syst Rev. 2005; : CD002738
- International consensus statement on allergy and rhinology: Rhinosinusitis.Int Forum Allergy rhinology. 2016; 6: S22-S209
- Topical steroid for chronic rhinosinusitis without polyps.Cochrane Database Syst Rev. 2011; : CD009274
- Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.Cochrane Database Syst Rev. 2016; 4: CD011996
- Topical steroids for nasal polyps.Cochrane Database Syst Rev. 2012; 12: CD006549
- Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis.F1000Res. 2018; 7: 412https://doi.org/10.12688/f1000research.13170.1
- Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.J Allergy Clin Immunol. 2015; 135 (e5): 701-709
- Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.J Investig Allergol Clin Immunol. 2011; 21: 51-58
- An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma.Clin Exp Allergy. 2001; 31: 138591
- New biologics for asthma.N Engl J Med. 2018; 378: 2533-2534
- Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.Ann Intern Med. 2011; 154: 573-582
- Pearlman Det al. Dupilumab in persistent asthma with elevated eosinophil levels.N Engl J Med. 2013; 368: 2455-2466
- Efficacy and safety of anti-Interleukin-5 therapy in patients with asthma: a systematic review and meta-analysis.PLoS One. 2016; 11: e0166833
- Tezepelumab in Adults with Uncontrolled Asthma.N Engl J Med. 2017; 377 ([Erratum in: N Engl J Med. 2019 May 23;380(21):2082. PMID: 28877011]): 936-946
- Desrosiers met al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.Lancet. 2019; 394: 1638-1650
- Effect of subcutaneous Dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial.JAMA. 2016; 315: 469-479
- Rabe KFet al. Liberty asthma QUEST: phase 3 randomized, double blind, placebo-controlled, parallel-group study to evaluate Dupilumab efficacy/safety in patients with uncontrolled, moderate-to-severe asthma.Adv Ther. 2018; 35: 737-748
- Two phase 3 trials of Dupilumab versus placebo in atopic dermatitis.N Engl J Med. 2016; 375: 2335-2348
- Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis.Respir Res. 2019; 20: 179
- Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis.J Allergy Clin Immunol. 2022; 149: 1286-1295
- Comparative Efficacy and Safety of Tezepelumab and Other Biologics in Patients with Inadequately Controlled Asthma According to Thresholds of Type 2 Inflammatory Biomarkers: A Systematic Review and Network Meta-Analysis.Cells. 2022; 11: 819
- Janus Kinases in Immune Cell Signaling.Immunol Rev. 2009; 228: 273-287
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention.Annu Rev Med. 2015; 66: 311-328
- JAK-STAT Signaling in Asthma.J Clin Invest. 2002; 109: 1279-1283
- Ruxolitinib Ameliorates Airway Hyperresponsiveness and Lung Inflammation in a Corticosteroid-Resistant Murine Model of Severe Asthma.Front Immunol. 2021; 12: 786238
- IgE versus IgG4 production can be differentially regulated by IL-10.J Immunol. 1998; 160: 3555-3561
- Cat allergen peptide immunotherapy reduces CD4+ T cell responses to cat allergen but does not alter suppression by CD4+ CD25+ T cells: a double-blind placebo-controlled study.Allergy. 2004; 59: 1097-1101
- Peptide Allergen Immunotherapy: A New Perspective in Olive-Pollen Allergy.Pharmaceutics. 2021; 13: 1007
- SPIREs: a new horizon for allergic disease treatment?.Expert Rev Clin Immunol. 2015; 11: 1173-1175
- Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes.Clin Transl Allergy. 2013; 3: O7
- WILLOW Investigators. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.N Engl J Med. 2020; 383: 2127-2137
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
